第一单位：
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.
作者：
Maddalena,Marconato [1]
;
Christopher,Hackenbruch [2]
;
Simon,Jäger [3]
;
Siri,Göpel [4]
;
Tetiana,Кirieieva [5]
;
Anatoliy,Gavrylov [6]
;
Harald,Fricke [7]
;
Michael,Hust [8]
;
Stefan,Dübel [9]
;
Christiane,Dings [10]
;
Thorsten,Lehr [11]
;
Mandy,Cuevas [12]
;
Michael,Bitzer [4]
;
Constantin,Klein [4]
;
Matthias,Schwab [13]
;
Hubert,Wirtz [14]
;
Jochen,Schneider [15]
;
Thomas,Bitter [16]
;
André,Frenzel [7]
;
Marie-Ann,Dhaen [7]
;
Andreas,Herrmann [7]
;
Gundram,Jung [17]
;
Juliane S,Walz [18]
;
Helmut R,Salih [19]
;
Jonas S,Heitmann [20]
作者单位：
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.
[1]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.
[2]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
[3]
Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
[4]
Communal Non-Profit Enterprise "City clinical hospital" of Dnipro city council, Therapy Department, Dnipro State Medical University, Dnipro, Ukraine.
[5]
Municipal Non-Profit Enterprise of Regional Council Regional Clinical Infectious Hospital, Kharkiv, Ukraine.
[6]
CORAT Therapeutics GmbH, Braunschweig, Germany.
[7]
Department of Medical Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany; Department of Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany.
[8]
Department of Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany.
[9]
Saarmetrics GmbH, Saarbrücken, Germany.
[10]
Saarmetrics GmbH, Saarbrücken, Germany; Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
[11]
TUD Dresden University of Technology, Faculty of Medicine (and University Hospital), Carl Gustav Carus Department of Otorhinolaryngology Head and Neck Surgery, Dresden, Germany.
[12]
Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.
[13]
Universitätsklinikum Leipzig Medizinische Klinik II, Leipzig, Germany.
[14]
Department of Internal Medicine II, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
[15]
Städtisches Klinikum Braunschweiq qGmbH Med. Klinik VII Klinik für Pneumoloqie und Beatmungsmedizin, Braunschweiq Germany.
[16]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
[17]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.
[18]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.
[19]
Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany. Electronic address: jonas.heitmann@med.uni-tuebingen.de.
[20]
DOI
10.1016/j.clinthera.2026.01.004
PMID
41654452
发布时间
2026-06-08
换一批
